Silicon Laboratories Recovery Slow, 2025 Outlook Positive, Stock Still Expensive, Morgan Stanley Says

MT Newswires Live2024-11-06

Silicon Laboratories (SLAB) revenue recovery from Q4 2023 lows has been slower than expected, and while next year's outlook is positive, the stock remains expensive, Morgan Stanley said in a note Tuesday.

The demand for the company's products is recovering slower than expected, with only modest improvements in orders and no signs of speeding up, the investment firm said.

In the most recent quarter, the company's revenue matched estimates at $166 million, but its profit margins missed expectations, Morgan Stanley said.

Following the company's lowered Q4 guidance, Morgan Stanley adjusted forecasts, expecting revenues to decline 25% in 2024 and grow 38% in 2025, with a slower recovery in margins and lower EPS estimates.

While the company promises long-term growth potential in the Internet of Things market, rebuilding confidence will take time, Morgan Stanley added.

Morgan Stanley cut its price target for Silicon Laboratories to $97 from $123, but maintained an equal-weight rating.

Price: 108.96, Change: +4.22, Percent Change: +4.02

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481635866?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-06 01:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2481635866","market":"sh","top_or_hot":-1,"title":"Silicon Laboratories Recovery Slow, 2025 Outlook Positive, Stock Still Expensive, Morgan Stanley Says","media":"MT Newswires Live","content":"<html><body><p> Silicon Laboratories (SLAB) revenue recovery from Q4 2023 lows has been slower than expected, and while next year's outlook is positive, the stock remains expensive, Morgan Stanley said in a note Tuesday.</p><p>The demand for the company's products is recovering slower than expected, with only modest improvements in orders and no signs of speeding up, the investment firm said.</p><p>In the most recent quarter, the company's revenue matched estimates at $166 million, but its profit margins missed expectations, Morgan Stanley said.</p><p>Following the company's lowered Q4 guidance, Morgan Stanley adjusted forecasts, expecting revenues to decline 25% in 2024 and grow 38% in 2025, with a slower recovery in margins and lower EPS estimates.</p><p>While the company promises long-term growth potential in the Internet of Things market, rebuilding confidence will take time, Morgan Stanley added.</p><p>Morgan Stanley cut its price target for Silicon Laboratories to $97 from $123, but maintained an equal-weight rating.</p><p>Price: 108.96, Change: +4.22, Percent Change: +4.02</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Silicon Laboratories Recovery Slow, 2025 Outlook Positive, Stock Still Expensive, Morgan Stanley Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSilicon Laboratories Recovery Slow, 2025 Outlook Positive, Stock Still Expensive, Morgan Stanley Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-11-06 01:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Silicon Laboratories (SLAB) revenue recovery from Q4 2023 lows has been slower than expected, and while next year's outlook is positive, the stock remains expensive, Morgan Stanley said in a note Tuesday.</p><p>The demand for the company's products is recovering slower than expected, with only modest improvements in orders and no signs of speeding up, the investment firm said.</p><p>In the most recent quarter, the company's revenue matched estimates at $166 million, but its profit margins missed expectations, Morgan Stanley said.</p><p>Following the company's lowered Q4 guidance, Morgan Stanley adjusted forecasts, expecting revenues to decline 25% in 2024 and grow 38% in 2025, with a slower recovery in margins and lower EPS estimates.</p><p>While the company promises long-term growth potential in the Internet of Things market, rebuilding confidence will take time, Morgan Stanley added.</p><p>Morgan Stanley cut its price target for Silicon Laboratories to $97 from $123, but maintained an equal-weight rating.</p><p>Price: 108.96, Change: +4.22, Percent Change: +4.02</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4127","symbol_name":"投资银行业与经纪业","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2481635866","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481635866","pubTimestamp":1730828236,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Silicon Laboratories  revenue recovery from Q4 2023 lows has been slower than expected, and while next year's outlook is positive, the stock remains expensive, Morgan Stanley said in a note Tuesday.The demand for the company's products is recovering slower than expected, with only modest improvements in orders and no signs of speeding up, the investment firm said.In the most recent quarter, the company's revenue matched estimates at $166 million, but its profit margins missed expectations, Morgan Stanley said.Following the company's lowered Q4 guidance, Morgan Stanley adjusted forecasts, expecting revenues to decline 25% in 2024 and grow 38% in 2025, with a slower recovery in margins and lower EPS estimates.While the company promises long-term growth potential in the Internet of Things market, rebuilding confidence will take time, Morgan Stanley added.Morgan Stanley cut its price target for Silicon Laboratories to $97 from $123, but maintained an equal-weight rating.Price: 108.96, Chan","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4127":"投资银行业与经纪业","LU0267386448.USD":"FIDELITY FIRST ALL COUNTRY WORLD \"A\" (USD) INC","LU0106831901.USD":"贝莱德世界金融基金A2","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU1363072403.SGD":"Fidelity Global Financial Services A-ACC-SGD","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU1548497426.USD":"安联环球人工智能AT Acc","LU0971096721.USD":"富达环球金融服务 A","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","LU1989772923.USD":"CPR Invest - Climate Action A2 Acc USD-H","LU0225283273.USD":"SCHRODER ISF GLOBAL EQUITY ALPHA \"A\" (USD) ACC","SLAB":"芯科实验室","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","BK4588":"碎股","BK4141":"半导体产品","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","BK4581":"高盛持仓","LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","BK4504":"桥水持仓"},"translate_title":"摩根士丹利表示，硅实验室复苏缓慢，2025年前景乐观，股价仍然昂贵","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SLAB":1},"content_text":"Silicon Laboratories (SLAB) revenue recovery from Q4 2023 lows has been slower than expected, and while next year's outlook is positive, the stock remains expensive, Morgan Stanley said in a note Tuesday.The demand for the company's products is recovering slower than expected, with only modest improvements in orders and no signs of speeding up, the investment firm said.In the most recent quarter, the company's revenue matched estimates at $166 million, but its profit margins missed expectations, Morgan Stanley said.Following the company's lowered Q4 guidance, Morgan Stanley adjusted forecasts, expecting revenues to decline 25% in 2024 and grow 38% in 2025, with a slower recovery in margins and lower EPS estimates.While the company promises long-term growth potential in the Internet of Things market, rebuilding confidence will take time, Morgan Stanley added.Morgan Stanley cut its price target for Silicon Laboratories to $97 from $123, but maintained an equal-weight rating.Price: 108.96, Change: +4.22, Percent Change: +4.02","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.31.7","shortVersion":"4.31.7","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481635866"}